Jayamas Medica Industri Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Jayamas Medica Industri Tbk. trades at Rp202 (market cap 5.47T, 307.7K 24h volume), while Chandra Asri Pacific Tbk. trades at Rp2,290 (market cap 194.65T, 172.66M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 35.6× Jayamas Medica Industri Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (172.66M versus 307.7K). Which is the better fit depends on your goals.
| OMED | TPIA | |
|---|---|---|
Market Cap | 5.47T | 194.65T |
Volume | 307.7K | 172.66M |
Lot | 3.08K | 1.73M |
Turnover | 61.63M | 398.77B |
Average Price | 200.3 | 2,309.55 |
Value | 61.63M | 398.77B |
Indicative Equilibrium Price | 202 | 2,270 |
Indicative Equilibrium Volume | 19.9K | 31.27K |
Trailing returns across standard periods
Latest headlines on both assets
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →